19/02/2026
Labiana Health has formalised a syndicated loan for a total amount of €37 million, which represents a significant step forward in optimising its financial structure.
These funds will be used to cancel and replace previous financing, partially repay ICO loans, partially finance the investment plan and cover operating needs.
The new structure:
✅ Extends maturities and establishes progressive repayments.
✅ Eliminates instruments with a potential dilutive effect on shareholders.
✅ Incorporates resources for CapEx and a working capital line.
💼 As a precondition to the transaction, the Company will carry out a capital increase with pre-emptive subscription rights for a maximum amount of €5.072 million, through the issue of up to 1,268,000 new shares at a price of €4 per share, allowing shareholders to maintain their proportional stake.
This is a strategic milestone for the company, strengthening its financial solidity, improving long-term visibility and laying the foundations for the ex*****on of its growth plan.
🔗https://www.labiana.com/wp-content/uploads/2026/02/05638_InfPriv_20260218_1.pdf
